Dr Alex Dickinson

Sphere Fluidics has appointed Dr Alex Dickinson to its Board of Directors

Sphere Fluidics has announced the appointment of Dr Alex Dickinson to its Board of Directors as a Non-Executive Director (NED).

Alex is a seasoned executive bringing substantial experience from the intersection of healthcare, life sciences and information technology to Sphere Fluidics’ leadership team.

He joins the Board as part of a series of significant senior appointments to drive forward the company’s global commercial expansion strategy, leveraging Alex’s extensive entrepreneurial and technical expertise to augment increased R&D efforts in areas of cutting-edge technological advancement.

From 2010 to 2017, Alex was Senior Vice President of Strategic Initiatives at Illumina. In this position, he founded and led development of the cloud-based BaseSpace platform, which remains the Company’s core bioinformatics offering, and ran its global population sequencing healthcare programmes.

Alex joined Illumina through the acquisition of Helixis, which he co-founded with Nobel laureate David Baltimore and led as CEO. He was also the Founder and CEO of Luxtera, a leading supercomputer chip company acquired by Cisco Systems in 2019.

Alex enthused: “What really excites me about joining Sphere Fluidics is the talent across the team and the capabilities of its microfluidic technology, with many cutting-edge developments already in the pipeline. Having worked closely with Dale at Illumina and Helixis, I am looking forward to joining him again to drive success at this pivotal stage in the company’s development.”